评论：曼佐尔，H.等人。成人和儿童慢性自发性荨麻疹中不同剂量方案的IgE靶向生物制剂奥马珠单抗的疗效：一项荟萃分析。2022年，，2579。
Comment on Manzoor, H. et al. Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis. 2022, , 2579.
作者信息
Tajerian Amin
机构信息
School of Medicine, Arak University of Medical Sciences, Arak 3819693345, Iran.
出版信息
Healthcare (Basel). 2024 Feb 28;12(5):553. doi: 10.3390/healthcare12050553.
Abstract
In December 2022, the paper "Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis" was published in the journal [...].
摘要
2022年12月，论文《成人和儿童人群中IgE靶向生物制剂奥马珠单抗不同给药方案治疗慢性自发性荨麻疹的疗效：一项荟萃分析》发表于期刊[...]。
相似文献
1
Comment on Manzoor, H. et al. Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis. 2022, , 2579.
Healthcare (Basel). 2024 Feb 28;12(5):553. doi: 10.3390/healthcare12050553.
2
Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis.
Healthcare (Basel). 2022 Dec 19;10(12):2579. doi: 10.3390/healthcare10122579.
3
Current and Future Approaches in Management of Chronic Spontaneous Urticaria Using Anti-IgE Antibodies.
Medicina (Kaunas). 2022 Jun 17;58(6):816. doi: 10.3390/medicina58060816.
4
Association Between Serum Total IgE Levels and Clinical Response to Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis.
J Allergy Clin Immunol Pract. 2023 Aug;11(8):2382-2389.e3. doi: 10.1016/j.jaip.2023.05.033. Epub 2023 May 30.
5
Update on Omalizumab for Urticaria: What's New in the Literature from Mechanisms to Clinic.
Curr Allergy Asthma Rep. 2018 May 9;18(5):33. doi: 10.1007/s11882-018-0787-5.
6
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
J Allergy Clin Immunol. 2011 Jul;128(1):202-209.e5. doi: 10.1016/j.jaci.2011.04.038. Epub 2011 Jun 2.
7
Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.
Theranostics. 2017 Mar 6;7(5):1266-1276. doi: 10.7150/thno.18304. eCollection 2017.
8
Anti-TPO IgG/Total IgE Ratio: Biomarker for Omalizumab Response Prediction in Chronic Spontaneous Urticaria.
Int Arch Allergy Immunol. 2023;184(9):866-869. doi: 10.1159/000532021. Epub 2023 Aug 9.
9
Efficacy of Omalizumab in Patients with Chronic Spontaneous Urticaria and Its Association with Serum IgE Levels and Eosinophil Count.
Acta Dermatovenerol Croat. 2019 Jun;27(2):101-106.
10
The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change.
Allergy. 2018 Mar;73(3):705-712. doi: 10.1111/all.13345. Epub 2017 Nov 27.
本文引用的文献
1
Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis.
Healthcare (Basel). 2022 Dec 19;10(12):2579. doi: 10.3390/healthcare10122579.
2
Adjunct therapy with probiotics for chronic urticaria in children: randomised placebo-controlled trial.
Allergy Asthma Clin Immunol. 2021 Apr 17;17(1):39. doi: 10.1186/s13223-021-00544-3.
3
Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data.
Allergy. 2018 Mar;73(3):576-584. doi: 10.1111/all.13339. Epub 2017 Dec 11.
4
Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells.
Sci Rep. 2017 Aug 21;7(1):8985. doi: 10.1038/s41598-017-09361-4.
5
Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
Allergy. 2016 Aug;71(8):1135-44. doi: 10.1111/all.12870. Epub 2016 Mar 31.
6
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
J Allergy Clin Immunol. 2013 Jul;132(1):101-9. doi: 10.1016/j.jaci.2013.05.013.
7
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
J Allergy Clin Immunol. 2011 Jul;128(1):202-209.e5. doi: 10.1016/j.jaci.2011.04.038. Epub 2011 Jun 2.
Zotero 插件